145 related articles for article (PubMed ID: 22532026)
1. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2012 Sep; 86(9):1369-78. PubMed ID: 22532026
[TBL] [Abstract][Full Text] [Related]
2. Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene.
Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Lukas C; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K
Arch Toxicol; 2012 Feb; 86(2):195-203. PubMed ID: 21892705
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure.
Golka K; Hermes M; Selinski S; Blaszkewicz M; Bolt HM; Roth G; Dietrich H; Prager HM; Ickstadt K; Hengstler JG
Pharmacogenet Genomics; 2009 Nov; 19(11):903-6. PubMed ID: 19801959
[TBL] [Abstract][Full Text] [Related]
4. Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk.
Lehmann ML; Selinski S; Blaszkewicz M; Orlich M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Dietrich H; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Löhlein D; Weistenhöfer W; Schöps W; Beg AE; Aslam M; Bánfi G; Romics I; Ickstadt K; Schwender H; Winterpacht A; Hengstler JG; Golka K
Arch Toxicol; 2010 Dec; 84(12):967-78. PubMed ID: 21063684
[TBL] [Abstract][Full Text] [Related]
5. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.
Tang W; Fu YP; Figueroa JD; Malats N; Garcia-Closas M; Chatterjee N; Kogevinas M; Baris D; Thun M; Hall JL; De Vivo I; Albanes D; Porter-Gill P; Purdue MP; Burdett L; Liu L; Hutchinson A; Myers T; Tardón A; Serra C; Carrato A; Garcia-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Black A; Jacobs EJ; Diver WR; Gapstur SM; Virtamo J; Hunter DJ; Fraumeni JF; Chanock SJ; Silverman DT; Rothman N; Prokunina-Olsson L
Hum Mol Genet; 2012 Apr; 21(8):1918-30. PubMed ID: 22228101
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".
Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG
Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501
[TBL] [Abstract][Full Text] [Related]
7. Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.
Selinski S; Blaszkewicz M; Ickstadt K; Gerullis H; Otto T; Roth E; Volkert F; Ovsiannikov D; Moormann O; Banfi G; Nyirady P; Vermeulen SH; Garcia-Closas M; Figueroa JD; Johnson A; Karagas MR; Kogevinas M; Malats N; Schwenn M; Silverman DT; Koutros S; Rothman N; Kiemeney LA; Hengstler JG; Golka K
Carcinogenesis; 2017 Dec; 38(12):1167-1179. PubMed ID: 29028944
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population.
Zhang Y; Sun Y; Chen T; Hu H; Xie W; Qiao Z; Ding N; Xie L; Li S; Wang W; Xing C; Wang Y; Qie Y; Wu C
Int J Mol Sci; 2014 Oct; 15(11):19330-41. PubMed ID: 25347272
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
11. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
Gangwar R; Ahirwar D; Mandhani A; Mittal RD
Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
[TBL] [Abstract][Full Text] [Related]
12. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
13. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
14. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
Pavanello S; Clonfero E
G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
[TBL] [Abstract][Full Text] [Related]
16. [Influence of occupational exposures in nonmuscle infiltration bladder cancer: preliminary results of a prospective study from October 2005 to February 2009].
Pecoux F; Fantoni JC; Berthon N; Lepage N; Sobaszek A; Sebbane N; Devos P; Biserte J
Prog Urol; 2011 Jun; 21(6):405-11. PubMed ID: 21620301
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
[TBL] [Abstract][Full Text] [Related]
18. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
Br J Cancer; 2005 Jun; 92(12):2262-5. PubMed ID: 15886698
[TBL] [Abstract][Full Text] [Related]
19. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
20. Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.
Schwender H; Selinski S; Blaszkewicz M; Marchan R; Ickstadt K; Golka K; Hengstler JG
PLoS One; 2012; 7(12):e51880. PubMed ID: 23284801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
